Clinical Trials Directory

Trials / Completed

CompletedNCT03153501

Efficiency and Safety of Pleural Biopsy Methods in the Diagnosis of Pleural Diseases

How Should be Invasive Diagnostic Algorithm in Pleural Diseases

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
164 (actual)
Sponsor
Eskisehir Osmangazi University · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Image-guided pleural biopsies, both ultrasound (US) or computed tomography (CT) guided, and medical thoracoscopy are important in the diagnosis of pleural disease. However, no consensus exists regarding which biopsy methods are appropriate for specific procedures. In this prospective study, the investigators aimed to compare CT-scan guided pleural biopsy using an Abrams' needle (CT-ANPB) with US-assisted pleural biopsy using a cutting needle (US-CNPB)and medical thoracoscopy with respect to both diagnostic yield and safety.

Detailed description

The primary end point of this study was the determination of the sensitivity and the complication rates of the invasive methods, Abrams needle pleural biopsy, tru-cut needle pleural biopsy, medical thoracoscopy with respect to the diagnosis of pleural disease.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCT-guided Abrams needle biopsy, US-guided cutting needle, medical thoracoscopy

Timeline

Start date
2011-02-08
Primary completion
2017-02-01
Completion
2017-04-30
First posted
2017-05-15
Last updated
2017-05-15

Locations

2 sites across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03153501. Inclusion in this directory is not an endorsement.